Pure Biologics Spólka Akcyjna (PUR) — Capital Reinvestment Ratio
Latest as of March 2024:
0.04x
Pure Biologics Spólka Akcyjna (PUR) has a Capital Reinvestment Ratio of 0.04x as of March 2024, meaning it reinvests 0% of its operating cash flow (zł2.04 Million) in capital expenditures (zł85.00K). See PUR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
zł2.04 Million
PLN
Capital Expenditures
zł85.00K
PLN
Data as of
Mar 2024
Most recent filing
Pure Biologics Spólka Akcyjna Capital Reinvestment Ratio (2019–2019)
This chart tracks Pure Biologics Spólka Akcyjna's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Pure Biologics Spólka Akcyjna (2019–2019)
Year-by-year Capital Reinvestment Ratio for Pure Biologics Spólka Akcyjna from 2019 to 2019. For live market cap and broader valuation context, see PUR market cap overview.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | zł5.33 Million | zł161.92K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow